Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Alingsås
Clinical trial register · Sweden

Clinical Trials in Alingsås, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Alingsås

16 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Vastra Gotaland Region
Not applicable
138
Alingsås, Gothenburg, Lidköping
2026-01-26
Recruiting
Vastra Gotaland Region
Observational
15
Alingsås
2025-11-14
Recruiting
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
NCT07174986Out of Hospital Cardiac Arrest, Ventricular Fibrillation, Defibrillation, CPR
Gabriel Riva
Phase 2/3
916
Halmstad, Karlstad, Kungälv, Alingsås, Borås, Gothenburg, Skövde, Trollhättan
2025-09-08
Active, closed
AbbVie
Phase 3
573
Danderyd, Solna, Alingsås, Örebro, Linköping
2025-06-17
Recruiting
AstraZeneca
Phase 3
15,100
Alingsås, Falun, Huddinge, Lidköping, Lund, Östersund, Stockholm, Umeå
2025-06-04
Recruiting
Sahlgrenska University Hospital
Observational
500
Alingsås, Kungälv, Uddevalla
2025-03-15
Recruiting
Virtual Reality (VR) Could Be a Good Alternative to Relaxing or Pain-relieving Medication
NCT06649383Virtual Reality, Distraction, Elderly (people Aged 65 or More)
Pether Jildenstal
Phase 4
90
Alingsås, Gothenburg
2024-12-16
Recruiting
AstraZeneca
Phase 3
3,850
Alingsås, Gothenburg, Jönköping, Karlstad, Mölndal, Stockholm, Uppsala, Västerås
2024-04-12
Recruiting
Satisfaction and Recovery After Distal Radius Fracture
NCT05818241Distal Radius Fracture
Sahlgrenska University Hospital
Observational
300
Mölndal, Alingsås
2023-01-12
Active, closed
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
NCT05284747Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization
Amgen
Phase 4
6,019
Alingsås, Gävle, Jönköping, Karlskrona, Linköping, Luleå, Lund, Molndahl
2022-10-26
Recruiting
Sahlgrenska University Hospital
Observational
4,000
Alingsås, Bäckefors, Bollnäs, Eksjö, Enköping, Gävle, Gothenburg, Helsingborg
2022-04-26
Active, closed
The TriggerHappy Trial
NCT04568993Trigger Finger, Trigger Thumb, Minimally Invasive Surgery
Sahlgrenska University Hospital
Not applicable
100
Alingsås
2020-10-01
Recruiting
Uppsala University
Not applicable
1,440
Uppsala, Alingsås, Borås, Falun, Gävle, Gothenburg, Jönköping, Kalmar
2019-09-16
Active, closed
AbbVie
Phase 3
1,242
Alingsås, Mölndal, Stockholm
2018-08-28
Recruiting
Halmstad County Hospital
Observational
5,300
Alingsås, Eskilstuna, Gothenburg, Halmstad, Jönköping, Ljungby, Lund, Malmö
2018-04-01
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/alings-s

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Alingsås.

How many clinical trials are recruiting in Alingsås?

11 of the 16 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alingsås), 16 studies
PhaseStudiesRecruitingShare
Observational5531.3%
Phase 35231.3%
Not applicable3218.8%
Phase 42112.5%
Phase 2/3116.3%

Most active sponsors

Lead sponsors with the most studies (Alingsås)
Lead sponsorStudiesRecruiting
Sahlgrenska University Hospital43
AbbVie30
AstraZeneca22
Vastra Gotaland Region22
Amgen10
Gabriel Riva11
Halmstad County Hospital11
Pether Jildenstal11
Uppsala University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.